Clinical Trials
2 trialsNCT01471847 2020-12-09
A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab
Novartis
Phase 1 Completed
NCT01572519 2020-11-20
A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Janssen Research & Development, LLC
Phase 1 Completed